A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
Clinical trial NCT01977651 · COMPLETED
Trial details
- NCT number
- NCT01977651
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-25
- Primary completion
- 2016-02-01
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.